HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Maria Q Baggstrom Selected Research
Maria Q Baggstrom Research Topics
Disease
15
Neoplasms (Cancer)
01/2022 - 09/2007
13
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2003
5
Lung Neoplasms (Lung Cancer)
01/2022 - 01/2011
3
Fatigue
01/2022 - 01/2017
3
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2020 - 02/2009
3
Disease Progression
10/2019 - 01/2003
3
Leukemia
07/2017 - 02/2009
2
Exanthema (Rash)
01/2022 - 01/2017
2
Hemorrhage
01/2022 - 01/2017
2
Anemia
07/2021 - 01/2017
2
Hypertension (High Blood Pressure)
10/2019 - 01/2017
2
Thrombocytopenia (Thrombopenia)
10/2017 - 01/2017
1
Lymphopenia (Lymphocytopenia)
01/2022
1
Leukopenia
01/2022
1
Edema (Dropsy)
07/2021
1
Adenocarcinoma of Lung
07/2021
1
Hyperglycemia
07/2021
1
Proteinuria
10/2019
1
Diarrhea
10/2019
1
Fever (Fevers)
10/2017
1
Central Nervous System Diseases (CNS Diseases)
01/2017
1
Brain Neoplasms (Brain Tumor)
01/2017
1
Mucositis
01/2017
1
Sarcoma (Soft Tissue Sarcoma)
01/2017
1
Neoplasm Metastasis (Metastasis)
01/2017
1
Neutropenia
01/2017
1
Pancreatic Neoplasms (Pancreatic Cancer)
01/2017
1
Thromboembolism
01/2017
1
Vomiting
06/2016
1
Nausea
06/2016
1
Prostatic Neoplasms (Prostate Cancer)
11/2011
1
Adenocarcinoma
11/2011
1
Small Cell Carcinoma
01/2009
1
Hypertriglyceridemia
01/2008
1
Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2008
Drug/Important Bio-Agent (IBA)
4
Irinotecan (Camptosar)
FDA Link
Generic
01/2020 - 09/2007
3
Paclitaxel (Taxol)
FDA Link
Generic
01/2022 - 09/2007
3
Carboplatin (JM8)
FDA Link
Generic
01/2022 - 02/2009
3
Platinum
IBA
01/2020 - 09/2007
3
Docetaxel (Taxotere)
FDA Link
11/2011 - 09/2007
2
carfilzomib
IBA
01/2020 - 10/2017
2
Erlotinib Hydrochloride (CP 358,774)
FDA Link
10/2019 - 01/2017
2
ErbB Receptors (EGF Receptor)
IBA
10/2019 - 01/2017
2
Bevacizumab (Avastin)
FDA Link
10/2019 - 01/2017
2
Vinorelbine (Navelbine)
FDA Link
Generic
09/2007 - 04/2007
1
vorolanib
IBA
01/2022
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2022
1
Nivolumab
IBA
01/2022
1
pembrolizumab
IBA
01/2022
1
Immune Checkpoint Inhibitors
IBA
01/2022
1
Alanine Transaminase (SGPT)
IBA
01/2022
1
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
01/2022
1
cyclopropapyrroloindole
IBA
01/2022
1
Everolimus
FDA Link
07/2021
1
130-nm albumin-bound paclitaxel
IBA
01/2021
1
MLN 8237
IBA
01/2021
1
Aurora Kinase A
IBA
01/2021
1
Proteasome Endopeptidase Complex (Proteasome)
IBA
10/2017
1
Proteasome Inhibitors
IBA
10/2017
1
Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)
IBA
07/2017
1
Cyclooxygenase 2 (Cyclooxygenase-2)
IBA
07/2017
1
Celecoxib (Celebrex)
FDA Link
07/2017
1
Sunitinib (Sutent)
FDA Link
01/2017
1
Tyrosine Kinase Inhibitors
IBA
01/2017
1
olaratumab
IBA
01/2017
1
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
01/2017
1
Antiemetics
IBA
06/2016
1
Dexamethasone (Maxidex)
FDA Link
Generic
06/2016
1
Serotonin 5-HT3 Receptor Antagonists
IBA
06/2016
1
Aprepitant (Emend)
FDA Link
06/2016
1
Pemetrexed (MTA)
FDA Link
01/2016
1
Folic Acid Antagonists
IBA
01/2016
1
temsirolimus
FDA Link
01/2016
1
TOR Serine-Threonine Kinases
IBA
01/2016
1
Androgens
IBA
11/2011
1
Estramustine
FDA Link
11/2011
1
gossypol acetic acid
IBA
10/2011
1
Gossypol
IBA
10/2011
1
Anaplastic Lymphoma Kinase
IBA
01/2011
1
Proteins (Proteins, Gene)
FDA Link
01/2011
1
Crizotinib
IBA
01/2011
1
sulindac sulfone (exisulind)
IBA
02/2009
1
Etoposide (VP 16)
FDA Link
Generic
02/2009
1
liposomal doxorubicin (Doxil)
FDA Link
01/2009
1
Type I DNA Topoisomerases (Topoisomerase I)
IBA
01/2009
1
PPAR gamma
IBA
01/2008
1
Bexarotene (LGD1069)
FDA Link
01/2008
1
Rosiglitazone (Avandia)
FDA Link
01/2008
1
Topotecan (Hycamtin)
FDA Link
Generic
01/2008
1
Ligands
IBA
01/2008
1
Insulin (Novolin)
FDA Link
01/2008
1
Atorvastatin (Lipitor)
FDA Link
01/2008
Therapy/Procedure
8
Drug Therapy (Chemotherapy)
01/2022 - 09/2007
7
Therapeutics
07/2021 - 01/2003
2
Adjuvant Chemotherapy
03/2015 - 01/2007
2
Radiotherapy
03/2015 - 11/2011
1
Proton Therapy
01/2022
1
Combination Drug Therapy (Combination Chemotherapy)
01/2017
1
Neoadjuvant Therapy
11/2011
1
Prostatectomy (Retropubic Prostatectomy)
11/2011